Ovid Therapeutics Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 68.3% | 68.3% | 63.1% |
| FY2022 | -41.0% | -41.0% | -34.9% |
| FY2023 | -59.6% | -59.6% | -36.3% |
| FY2024 | -38.7% | -38.7% | -28.7% |
| FY2025 | -13.3% | -13.3% | -11.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 68.3% | 68.3% | 63.1% |
| FY2022 | -41.0% | -41.0% | -34.9% |
| FY2023 | -59.6% | -59.6% | -36.3% |
| FY2024 | -38.7% | -38.7% | -28.7% |
| FY2025 | -13.3% | -13.3% | -11.5% |